The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer

Molecular Carcinogenesis

Volumn 30, Issue 1, 2001, Pages 71-78

  Spurdle, Amanda B ^a,b   Purdie, David M ^a   Webb, Penelope M ^a   Chen, Xiaoqing ^a   Green, Adele ^a   Chenevix Trench, Georgia ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Microsomal epoxide hydrolase gene; Ovarian cancer; Polymorphism

Indexed keywords

CIGARETTE SMOKE; EPOXIDE HYDROLASE; GENE PRODUCT; HISTIDINE; MICROSOME ENZYME; PROTEIN EPHX; TYROSINE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENZYME SUBSTRATE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; EPOXIDE HYDROLASES; FEMALE; GENOTYPE; HISTIDINE; HUMANS; MICROSOMES; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; TYROSINE;

EID: 0035143142     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200101)30:1<71::AID-MC1015>3.0.CO;2-9     Document Type: Article

References (27)

1. Cancer in Australia 1995: Incidence and mortality data for 1995 and selected data for 1996
2. Hereditary ovarian cancer: Molecular genetics and clinical implications
3. Environmental and heritable factors in the causation of cancer
4. Mortality in relation to smoking: 20 Years' observations on female British doctors
5. Cigarette smoking and epithelial ovarian cancer by histologic type
6. Mammalian epoxide hydrases: Inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds
7. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide
8. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants
9. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer
10. The p53 tumor suppressor gene frequently is altered in gynecologic cancers
11. Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations
12. Differences in risk factors for epithelial ovarian cancer by histologic type: Results of a case-control study
13. Reproductive factors and risk of ovarian cancer: A prospective study
14. Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors
15. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
16. Hormone replacement therapy and risk of epithelial ovarian cancer
17. Epithelial ovarian cancer: Influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression
18. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study. Survey of Women's Health Study Group
19. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer
20. CYP17 promotor polymorphism and ovarian cancer risk
21. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: Consistency of findings in women and men
22. A simple salting out procedure for extracting DNA from human nucleated cells
23. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique
24. The relationship between borderline ovarian tumors and epithelial ovarian carcinoma: Epidemiologic, pathologic, and molecular aspects
25. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: Risk of ovarian cancer by histological subtype